fbpx

Fresenius SE & Co KGaA

FREG.DE

$38.53

Closing

▼-0.22%

1D

▲9.48%

YTD

FREG

BBG001S9NDP6

Exchange

Sector

Market cap

$21.54B

Volume

987,993

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$21.54B

Analysts' Rating

BUY

Price Target (Mean)

41.42

Total Analysts

20

P/E

43.45

Operating Margin

10.85%

Beta

1.05

Revenue Growth

3.45%

52 week high

$38.91

52 week low

$25.52

Div. Yield

0.00%

EPS Growth

-15.58

Company Profile

Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.